These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10958945)

  • 1. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers.
    Przybojewska B; Jagiello A; Jalmuzna P
    Cancer Genet Cytogenet; 2000 Aug; 121(1):73-7. PubMed ID: 10958945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61.
    Hong SJ; Lee T; Park YS; Lee KO; Chung BH; Lee SH
    Yonsei Med J; 1996 Dec; 37(6):371-9. PubMed ID: 9048488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population.
    Pandith AA; Shah Z; Rasool R; Dil-Afroze ; Yousuf A; Parveen N; Wani S; Siddiqi M
    Tumori; 2010; 96(6):993-8. PubMed ID: 21388064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of RAS gene family in specimens of bladder cancer.
    Karimianpour N; Mousavi-Shafaei P; Ziaee AA; Akbari MT; Pourmand G; Abedi A; Ahmadi A; Afshin Alavi H
    Urol J; 2008; 5(4):237-42. PubMed ID: 19101897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of H-ras gene point mutations in 50 cases of bladder carcinoma.
    Saito S; Hata M; Fukuyama R; Sakai K; Kudoh J; Tazaki H; Shimizu N
    Int J Urol; 1997 Mar; 4(2):178-85. PubMed ID: 9179693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.
    Czerniak B; Cohen GL; Etkind P; Deitch D; Simmons H; Herz F; Koss LG
    Hum Pathol; 1992 Nov; 23(11):1199-204. PubMed ID: 1427748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing.
    Grimmond SM; Raghavan D; Russell PJ
    Urol Res; 1992; 20(2):121-6. PubMed ID: 1553789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low incidence of mutations in codon 12 of the c-K-ras gene in bladder cancer].
    Ejarque MJ; Villanueva A; Chechile G; Regalado R; Errando C; Algaba F; Capella G; Lluis F; Villavicencio H; Vicente J
    Actas Urol Esp; 1995 Sep; 19(8):599-603. PubMed ID: 8669326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.
    Toyooka S; Tsukuda K; Ouchida M; Tanino M; Inaki Y; Kobayashi K; Yano M; Soh J; Kobatake T; Shimizu N; Shimizu K
    Oncol Rep; 2003; 10(5):1455-9. PubMed ID: 12883723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors.
    Vageli D; Kiaris H; Delakas D; Anezinis P; Cranidis A; Spandidos DA
    Cancer Lett; 1996 Oct; 107(2):241-7. PubMed ID: 8947520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Enomoto T; Ward JM; Perantoni AO
    Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras oncogene activation in benign and malignant colorectal tumours.
    Spandidos DA; Glarakis IS; Kotsinas A; Ergazaki M; Kiaris H
    Tumori; 1995; 81(3 Suppl):7-11. PubMed ID: 7571058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of N-ras gene mutations in urothelial cell carcinomas of the urinary bladder in the Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Bhat AY; Wani SM; Siddiqi MA
    Asian Pac J Cancer Prev; 2009; 10(6):1063-6. PubMed ID: 20192584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-RAS mutation in transitional cell carcinoma of urinary bladder.
    Ayan S; Gokce G; Kilicarslan H; Ozdemir O; Yildiz E; Gultekin EY
    Int Urol Nephrol; 2001; 33(2):363-7. PubMed ID: 12092657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of H-, K- and N-ras oncogene mutations in cytological specimens of laryngeal tumours.
    Rizos E; Sourvinos G; Arvanitis DA; Velegrakis G; Spandidos DA
    Oral Oncol; 1999 Nov; 35(6):561-3. PubMed ID: 10705090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of H-ras mutations in human bladder cancer detected by direct sequencing.
    Burchill SA; Neal DE; Lunec J
    Br J Urol; 1994 May; 73(5):516-21. PubMed ID: 8012773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer.
    Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z
    Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of human bladder carcinomas for the presence of Ha-ras codon 12 mutation.
    Cattan N; Saison-Behmoaras T; Mari B; Mazeau C; Amiel JL; Rossi B; Gioanni J
    Oncol Rep; 2000; 7(3):497-500. PubMed ID: 10767358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.